Equities
  • Price (EUR)0.416
  • Today's Change0.012 / 2.97%
  • Shares traded--
  • 1 Year change-54.54%
  • Beta--
Data delayed at least 15 minutes, as of Jul 19 2024 18:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Renergen Limited is a South Africa-based onshore natural gas explorer and integrated producer of both liquefied helium (LHe) and liquefied natural gas (LNG), both of which are produced from the natural gas found in its Virginia Gas Project. The Virginia Gas Project comprises production rights of approximately 187,000 hectares of gas fields across Welkom, Virginia and Theunissen, in the Free State. Its segments include Tetra4, Cryovation, Renergen US and Corporate head office. Tetra4 segment explores, produces and sells LNG and is focused on producing and selling LHe. It operates in the Gauteng Province, Free State Province and Mpumalanga Province in the town of Evander. Cryovation segment develops the Cryo-Vacc technology, which enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power. Renergen US segment assists with various fund raising and business development activities of the group in the United States market.

  • Revenue in ZAR (TTM)28.95m
  • Net income in ZAR-110.27m
  • Incorporated2014
  • Employees69.00
  • Location
    RENERGEN Ltd1 Bompas Road, Dunkeld WestDUNKELD 2196South AfricaZAF
  • Phone+27 100456000
  • Websitehttps://renergen.co.za/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.